This inventor holds 4 USPTO granted patents and 2 published patent applications and 4 EPO patents. Top assignees: Oncotherapy Science, Incorporated, Sage Therapeutics, Inc.. Active years: 2015-2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2015-2024
Title: The Innovative Contributions of Robert Borbo Kargbo
Introduction
Robert Borbo Kargbo is a notable inventor based in Guilderland, NY (US). He has made significant contributions to the field of neuroactive steroids, holding a total of 4 patents. His work focuses on the development of pharmaceutical compositions that have potential applications in sedation and anesthesia.
Latest Patents
Kargbo's latest patents include innovative formulations of neuroactive steroids. These compounds are designed to act as GABA modulators, which can be crucial in various medical treatments. The patents describe neuroactive steroids of a specific formula, along with their pharmaceutically acceptable salts. The inventions also encompass methods of use and treatment, particularly for inducing sedation and/or anesthesia.
Career Highlights
Throughout his career, Kargbo has worked with prominent companies in the pharmaceutical industry. Notable among these are Sage Therapeutics, Inc. and Oncotherapy Science, Incorporated. His experience in these organizations has contributed to his expertise in neuroactive compounds and their therapeutic applications.
Collaborations
Kargbo has collaborated with several professionals in his field, including Gabriel Martinez Botella and Boyd Lynn Harrison. These collaborations have likely enriched his research and development efforts, leading to innovative solutions in the realm of neuroactive steroids.
Conclusion
Robert Borbo Kargbo's contributions to the field of neuroactive steroids and his innovative patents highlight his role as a significant inventor. His work continues to influence the development of pharmaceutical treatments aimed at improving patient care.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

